|
|
Industry Liaison Forum
The Industry Liaison Forum (ILF) is an initiative of the International AIDS Society (IAS) with a mission to accelerate scientifically promising, ethical HIV research in resource-limited countries, with a particular focus on the role and responsibilities of industry as sponsors and supporters of research.

IAS-ILF and 15 other leading public and private sector organizations released a comprehensive research agenda designed to significantly advance global responses to HIV in women, girls and children.
The new consensus statement, Asking the Right Questions: Advancing an HIV Research Agenda for Women and Children, includes 20 specific recommendations to expand and improve responses to the HIV-related challenges facing women and children worldwide.
Read the related press release
What's New

New ILF Strategic Plan 2012-2014
The new strategic plan outlining ILF’s priorities for the next three years was adopted at IAS 2011, and is available for viewing and download.
Gender in Editorial Policy
In line with the ILF's Consensus Statement recommendation that research data should be disaggregated by sex, we would like to congratulate The Lancet for adopting the Editorial Gender Policy. Notably, the Journal of the International AIDS Society (JIAS) introduced this policy earlier this year. Read more about the policy here: http://jiasociety.org/content/14/1/11.
IAS 2011 Session Reports
Challenges in the Procurement and Development of Paediatric Antiretroviral Formulations
What does the future of ARV-based prevention look like?
Operational and Implementation Challenges in Scaling Up PMTCT Programmes in Resource-‐Limited Settings
10 Years of ILF
Read the related press release
|
25 November 2011
VOICE Trial Team Announces Closure of Tenofovir Gel Trial Arm in VOICE Trial
21 September 2011
Viramune® (nevirapine) prolonged-release once-daily formulation for the treatment of HIV-1 infection receives approval in the EU
21 March 2011
Despite great strides, more is needed in pediatric AIDS research
Laura Guay (Elizabeth Glacer Pediatric AIDS Foundation)
8 March 2011
Time for gender mainstreaming in editorial policies
27 January 2011
Tibotec signs multiple agreements with generic manufacturers to provide access to new HIV treatment
Articles from previous years are available here
 |
 |
2011 Sponsoring Industry Partners |
 |




Merck & Co., Inc.


|